Jones Financial Companies
AXSM icon

Jones Financial Companies’s Axsome Therapeutics AXSM Stock Holding History

Jones Financial Companies’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$704K Buy
2,912
+1,419
+95% +$308K ﹤0.01% 2059
2026
Q1 		$233K Buy
1,493
+1,198
+406% +$207K ﹤0.01% 2338
2025
Q4 		$53.9K Buy
295
+43
+17% +$6K ﹤0.01% 2485
2025
Q3 		$29.5K Sell
252
-52
-17% -$5.86K ﹤0.01% 2598
2025
Q2 		$31.4K Hold
304
– – ﹤0.01% 2411
2025
Q1 		$36K Hold
304
– – ﹤0.01% 2187
2024
Q4 		$25.7K Buy
304
+25
+9% +$2.3K ﹤0.01% 2143
2024
Q3 		$25K Buy
279
+135
+94% +$11.8K ﹤0.01% 1872
2024
Q2 		$11.6K Buy
+144
New +$10.7K ﹤0.01% 1715

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jones Financial Companies's AXSM Position: Q2 2026 in Review

Jones Financial Companies increased its Axsome Therapeutics (AXSM) stake by 95% in Q2 2026, buying an estimated $308K and bringing the position to 2,912 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #2059.

Jones Financial Companies first reported a position in AXSM in Q2 2024 and has held it in 9 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Jones Financial Companies held 2,912 shares of Axsome Therapeutics worth $704K as of Q2 2026.
  • Jones Financial Companies bought 1,419 Axsome Therapeutics shares in Q2 2026, an estimated $308K.
  • Axsome Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2059 holding.
  • Jones Financial Companies first reported a position in Axsome Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.